X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-06-10 | DXCM | Dexcom Inc | Sylvain Jereme M | EVP CFO | S - Sale | $115.05 | -745 | 84,948 | -1% | -$85,713 | ||||||
2024-06-10 | DXCM | Dexcom Inc | Stern Sadie | EVP CHRO | S - Sale | $115.05 | -427 | 75,877 | -1% | -$49,127 | ||||||
2024-06-10 | DXCM | Dexcom Inc | Leach Jacob Steven | EVP COO | S - Sale | $115.05 | -745 | 312,873 | 0% | -$85,713 | ||||||
2024-06-11 | TMCI | Treace Medical Concepts, Inc. | Treace John T. | CEO, 10% | P - Purchase | $5.88 | +45,000 | 11,712,224 | 0% | +$264,600 | ||||||
2024-06-10 | RMD | Resmed Inc | Sandercock Brett | CFO | S - Sale | $209.81 | -1,000 | 91,056 | -1% | -$209,810 | ||||||
2024-06-10 | PODD | Insulet Corp | Scannell Timothy J | Dir | S - Sale | $190.51 | -7,000 | 35,586 | -16% | -$1,333,570 | ||||||
2024-06-10 | PODD | Insulet Corp | Field Mark N | SVP, CTO | S - Sale | $190.43 | -2,131 | 14,375 | -13% | -$405,806 | ||||||
2024-06-06 | NMTC | Neuroone Medical Technologies Corp | Christianson Mark | Business Development Dir | S - Sale | $0.88 | -2,189 | 295,035 | -1% | -$1,918 | ||||||
2024-06-10 | BDX | Becton Dickinson & Co | Spoerel Thomas J | SVP,Controller, Chief Acct Off | S - Sale | $239.31 | -300 | 2,093 | -13% | -$71,793 | ||||||
| D | 2024-06-07 | RMD | Resmed Inc | Farrell Michael J. | CEO | S - Sale+OE | $211.66 | -14,683 | 444,889 | -3% | -$3,107,739 | |||||
| M | 2024-05-28 | CTCX | Carmell Corp | Shukla Rajiv | COB, CEO, 10% | P - Purchase | $2.57 | +4,120 | 4,322,011 | 0% | +$10,578 | |||||
2024-06-05 | NMTC | Neuroone Medical Technologies Corp | Christianson Mark | Business Development Dir | S - Sale | $0.88 | -25,800 | 297,224 | -8% | -$22,663 | ||||||
| D | 2024-06-04 | NVCR | Novocure Ltd | Vernon W Anthony | Dir | S - Sale+OE | $23.89 | -964 | 334,683 | 0% | -$23,033 | |||||
| D | 2024-06-04 | NVCR | Novocure Ltd | Scannell Timothy J | Dir | S - Sale+OE | $23.89 | -964 | 10,945 | -8% | -$23,027 | |||||
| D | 2024-06-04 | NVCR | Novocure Ltd | Leung Gabriel | Dir | S - Sale+OE | $23.89 | -964 | 161,367 | -1% | -$23,025 | |||||
2024-06-06 | STIM | Neuronetics, Inc. | Cascella Robert | Dir | P - Purchase | $2.05 | +50,000 | 244,098 | +26% | +$102,550 | ||||||
2023-12-01 | ARAY | Accuray Inc | Chalke Sandeep | SVP, Chief Commercial Officer | S - Sale | $1.70 | -26,799 | 531,341 | -5% | -$45,612 | ||||||
2024-06-04 | ARAY | Accuray Inc | Pervaiz Ali | SVP CFO | S - Sale | $1.70 | -2,701 | 402,542 | -1% | -$4,597 | ||||||
| D | 2024-06-03 | GKOS | Glaukos Corp | Gilliam Joseph E | Pres, COO | S - Sale+OE | $113.50 | -2,500 | 101,845 | -2% | -$283,751 | |||||
2024-06-03 | PEN | Penumbra Inc | Roberts Johanna | EVP, Gen. Counsel, Secretary | S - Sale | $188.90 | -600 | 62,888 | -1% | -$113,339 | ||||||
2024-06-03 | LUNG | Pulmonx Corp | Lehman David Aaron | GC | S - Sale | $6.97 | -5,475 | 209,113 | -3% | -$38,161 | ||||||
2024-06-03 | LUNG | Pulmonx Corp | Rose Geoffrey Beran | Chief Commercial Officer | S - Sale | $6.97 | -4,297 | 301,203 | -1% | -$29,950 | ||||||
2024-06-04 | PODD | Insulet Corp | Borio Luciana | Dir | S - Sale | $182.58 | -360 | 3,298 | -10% | -$65,729 | ||||||
2024-06-03 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $1.02 | +6,144 | 15,427,527 | 0% | +$6,267 | ||||||
2024-06-03 | IRTC | Irhythm Technologies, Inc. | Rosenbaum Marc W. | Chief Accounting Officer | S - Sale | $88.91 | -510 | 8,174 | -6% | -$45,344 | ||||||
2024-06-03 | IRTC | Irhythm Technologies, Inc. | Shrishrimal Sumi | EVP, Chief Risk Officer | S - Sale | $88.91 | -1,131 | 23,298 | -5% | -$100,557 | ||||||
2024-06-03 | IRMD | Iradimed Corp | Allen Monty K | Dir | S - Sale | $43.37 | -1,947 | 18,053 | -10% | -$84,432 | ||||||
2024-06-03 | CATX | Perspective Therapeutics, Inc. | Woods Lori A | Dir | P - Purchase | $1.46 | +34,246 | 1,553,984 | +2% | +$49,992 | ||||||
2024-06-04 | RDGL | Vivos Inc | Korenko Michael K | CEO, Pres | P - Purchase | $0.17 | +50,000 | 10,135,090 | 0% | +$8,435 | ||||||
| D | 2024-05-30 | GKOS | Glaukos Corp | Kliman Gilbert H | Dir | S - Sale+OE | $112.00 | -5,000 | 32,336 | -13% | -$560,000 | |||||
| D | 2024-06-03 | BSX | Boston Scientific Corp | Carruthers Wendy | EVP, HR | S - Sale+OE | $75.33 | -6,983 | 45,628 | -13% | -$526,029 | |||||
2024-05-31 | TMCI | Treace Medical Concepts, Inc. | Treace James T | Dir | P - Purchase | $6.05 | +25,000 | 1,695,624 | +1% | +$151,328 | ||||||
2024-05-30 | RCEL | Avita Medical, Inc. | O'Toole David D | CFO | P - Purchase | $8.90 | +1,000 | 21,974 | +5% | +$8,900 | ||||||
2024-05-30 | TNDM | Tandem Diabetes Care Inc | Allen Dick | Dir | S - Sale | $51.68 | -5,000 | 47,288 | -10% | -$258,400 | ||||||
2024-05-30 | OBIO | Orchestra Biomed Holdings, Inc. | Little William Reed | See Remarks | P - Purchase | $7.00 | +4,000 | 307,859 | +1% | +$28,000 | ||||||
2024-05-31 | CATX | Perspective Therapeutics, Inc. | Hunt Jonathan Robert | CFO | P - Purchase | $1.40 | +25,006 | 341,716 | +8% | +$35,007 | ||||||
2024-05-31 | CATX | Perspective Therapeutics, Inc. | Williamson Robert F III | Dir | P - Purchase | $1.38 | +55,000 | 427,455 | +15% | +$75,900 | ||||||
2024-05-31 | DXCM | Dexcom Inc | Brown Michael Jon | EVP GC | S - Sale | $119.24 | -652 | 67,560 | -1% | -$77,744 | ||||||
| M | 2024-05-29 | CTCX | Carmell Corp | Cassaday Bryan J. | CFO | P - Purchase | $2.55 | +395 | 2,335 | +20% | +$1,009 | |||||
| AM | 2023-11-07 | NARI | Inari Medical, Inc. | Milder Donald B | Dir | P - Purchase | $53.44 | +56,100 | 3,286,714 | +2% | +$2,998,063 | |||||
2024-05-30 | ATRC | Atricure, Inc. | Privitera Salvatore | Chief Technical Officer | P - Purchase | $22.25 | +5,000 | 103,290 | +5% | +$111,250 | ||||||
2024-05-28 | NARI | Inari Medical, Inc. | Hykes Andrew | Pres, CEO | S - Sale | $50.00 | -3,000 | 471,124 | -1% | -$150,000 | ||||||
2024-05-28 | NARI | Inari Medical, Inc. | Hoffman William | Dir | S - Sale | $50.13 | -60,000 | 865,359 | -6% | -$3,007,800 | ||||||
2024-05-30 | ICUI | Icu Medical Inc/de | Voigtlander Christian B. | COO | S - Sale | $103.95 | -12,539 | 0 | -100% | -$1,303,485 | ||||||
2024-05-29 | TMCI | Treace Medical Concepts, Inc. | Treace James T | Dir | P - Purchase | $5.20 | +25,000 | 1,670,624 | +2% | +$130,063 | ||||||
| DM | 2024-05-28 | NEPH | Nephros Inc | Amron Arthur H | Dir | P - Purchase | $2.24 | +5,000 | 103,463 | +5% | +$11,176 | |||||
| D | 2024-05-29 | BSX | Boston Scientific Corp | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale+OE | $75.10 | -63,802 | 28,022 | -69% | -$4,791,447 | |||||
| M | 2024-05-28 | ARAY | Accuray Inc | Whitters Joseph E | Dir | P - Purchase | $1.56 | +100,000 | 561,053 | +22% | +$156,045 | |||||
2024-05-29 | CATX | Perspective Therapeutics, Inc. | Williamson Robert F III | Dir | P - Purchase | $1.33 | +30,031 | 372,455 | +9% | +$40,014 | ||||||
2024-05-29 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.93 | +14,282 | 15,421,383 | 0% | +$13,319 | ||||||
2024-05-29 | HAE | Haemonetics Corp | Basil Michelle L | EVP, GC | S - Sale | $88.08 | -12,990 | 31,257 | -29% | -$1,144,208 | ||||||
2024-05-29 | HAE | Haemonetics Corp | Strong Stewart W | Pres, Global Hospital | S - Sale | $87.53 | -8,857 | 18,196 | -33% | -$775,253 | ||||||
| D | 2024-05-28 | BSX | Boston Scientific Corp | Butcher Arthur C | EVP,Grp Pres, MedSurg, APAC | S - Sale+OE | $75.34 | -14,011 | 22,736 | -38% | -$1,055,590 | |||||
2024-05-28 | TMCI | Treace Medical Concepts, Inc. | Treace James T | Dir | P - Purchase | $5.07 | +50,000 | 1,645,624 | +3% | +$253,475 | ||||||
| D | 2024-05-28 | PODD | Insulet Corp | Scannell Timothy J | Dir | S - Sale+OE | $180.90 | -3,300 | 42,586 | -7% | -$596,970 | |||||
| M | 2024-05-23 | CTCX | Carmell Corp | Shukla Rajiv | COB, CEO, 10% | P - Purchase | $2.54 | +4,039 | 4,317,891 | 0% | +$10,241 | |||||
| D | 2024-05-27 | UBI | Universal Biosensors Inc | Coleman Craig E. | Dir, 10% | P - Purchase | $0.11 | +1,421,293 | 88,480,120 | +2% | +$156,342 | |||||
2024-05-23 | IART | Integra Lifesciences Holdings Corp | Essig Stuart | Exec. COB | P - Purchase | $28.49 | +52,641 | 1,753,434 | +3% | +$1,499,979 | ||||||
| M | 2024-05-17 | SRTS | Sensus Healthcare, Inc. | Heinrich John | Dir | S - Sale | $6.17 | -20,000 | 59,940 | -25% | -$123,416 | |||||
2024-05-22 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.88 | +32,752 | 15,407,101 | 0% | +$28,884 | ||||||
2024-05-22 | LUNG | Pulmonx Corp | Rose Geoffrey Beran | Chief Commercial Officer | S - Sale | $8.71 | -1,184 | 305,500 | 0% | -$10,313 | ||||||
2024-05-23 | INFU | Infusystem Holdings, Inc | Boyd Ralph F Jr | Dir | P - Purchase | $7.13 | +4,000 | 6,000 | +200% | +$28,520 | ||||||
2024-05-22 | INFU | Infusystem Holdings, Inc | Huss Beverly A | Dir | P - Purchase | $6.86 | +4,300 | 4,300 | New | +$29,486 | ||||||
2024-05-22 | TMCI | Treace Medical Concepts, Inc. | Mott Richard W | Dir | P - Purchase | $4.99 | +12,100 | 1,054,944 | +1% | +$60,425 | ||||||
| DM | 2024-05-22 | BSX | Boston Scientific Corp | Brennan Daniel J. | EVP, CFO | S - Sale+OE | $75.57 | -112,075 | 223,921 | -33% | -$8,469,752 | |||||
| DM | 2024-05-21 | BSX | Boston Scientific Corp | Brown Vance R | SVP, GC, Corp. Secretary | S - Sale+OE | $75.79 | -33,043 | 32,326 | -51% | -$2,504,239 | |||||
2024-05-22 | SYK | Stryker Corp | Fletcher Robert S | VP, GC | S - Sale | $332.99 | -2,007 | 9,036 | -18% | -$668,308 | ||||||
2024-05-20 | PEN | Penumbra Inc | Elsesser Adam | CEO, Pres | S - Sale | $200.98 | -15,000 | 947,582 | -2% | -$3,014,734 | ||||||
| M | 2024-05-20 | CTCX | Carmell Corp | Shukla Rajiv | COB, CEO, 10% | P - Purchase | $2.37 | +6,738 | 4,313,852 | 0% | +$15,988 | |||||
2024-04-04 | CTCX | Carmell Corp | Shukla Rajiv | COB, CEO, 10% | P - Purchase | $2.88 | +8,680 | 4,307,114 | 0% | +$24,998 | ||||||
2024-05-21 | IART | Integra Lifesciences Holdings Corp | Hill Barbara B | Dir | P - Purchase | $27.40 | +36,350 | 136,672 | +36% | +$995,816 | ||||||
| A | 2024-05-15 | RMD | Resmed Inc | De Witte Jan | Dir | S - Sale | $218.29 | -360 | 7,519 | -5% | -$78,584 | |||||
2024-05-21 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.90 | +20,000 | 15,374,349 | 0% | +$18,016 | ||||||
2024-05-20 | PLSE | Pulse Biosciences, Inc. | Barrett Burke Thomas | Pres, CEO | P - Purchase | $8.56 | +10,000 | 10,000 | New | +$85,600 | ||||||
| AM | 2024-05-16 | OBIO | Orchestra Biomed Holdings, Inc. | Hochman David P | See Remarks | P - Purchase | $4.99 | +5,000 | 662,004 | +1% | +$24,950 | |||||
2024-05-20 | NARI | Inari Medical, Inc. | Chambers Rebecca | Dir | S - Sale | $45.39 | -964 | 9,944 | -9% | -$43,756 | ||||||
| D | 2024-05-20 | INFU | Infusystem Holdings, Inc | Steele Barry G | EVP, CFO | P - Purchase | $6.47 | +3,000 | 131,550 | +2% | +$19,398 | |||||
| D | 2024-05-20 | INFU | Infusystem Holdings, Inc | Funke Jerod | EVP-CHRO | P - Purchase | $6.39 | +1,000 | 1,000 | New | +$6,388 | |||||
| D | 2024-05-21 | INFU | Infusystem Holdings, Inc | Chupa Addam | EVP, CIO | P - Purchase | $6.67 | +1,000 | 46,685 | +2% | +$6,670 | |||||
| D | 2024-05-20 | INFU | Infusystem Holdings, Inc | Gendron Paul Andrew | Dir | P - Purchase | $6.54 | +5,000 | 125,000 | +4% | +$32,700 | |||||
| D | 2024-05-20 | HAE | Haemonetics Corp | Strong Stewart W | Pres, Global Hospital | S - Sale+OE | $95.11 | -686 | 18,196 | -4% | -$65,245 | |||||
| M | 2024-05-17 | SSII | Ss Innovations International, Inc. | Cohen Barry F | COO - Americas | P - Purchase | $3.31 | +2,871 | 8,956,855 | 0% | +$9,489 | |||||
| M | 2024-05-17 | HAE | Haemonetics Corp | Llorens Josep | EVP, Global Manufacturing | S - Sale | $94.96 | -1,809 | 21,310 | -8% | -$171,786 | |||||
| DM | 2024-05-17 | HAE | Haemonetics Corp | Basil Michelle L | EVP, GC | S - Sale+OE | $95.05 | -2,677 | 31,257 | -8% | -$254,443 | |||||
2024-05-20 | AURX | Nuo Therapeutics, Inc. | Sheedy Charles E | 10% | P - Purchase | $0.75 | +100,000 | 11,315,865 | +1% | +$75,000 | ||||||
2024-05-17 | SGHT | Sight Sciences, Inc. | Bauerlein Alison | CFO | S - Sale | $5.42 | -13,066 | 413,182 | -3% | -$70,870 | ||||||
| M | 2024-05-16 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $1.03 | +54,236 | 15,354,349 | 0% | +$55,863 | |||||
2024-05-16 | TCMD | Tactile Systems Technology Inc | Birkemeyer Elaine M. | CFO | S - Sale | $13.68 | -3,041 | 61,295 | -5% | -$41,590 | ||||||
| D | 2024-05-16 | LMAT | Lemaitre Vascular Inc | Ross Bridget A | Dir | S - Sale+OE | $77.99 | -5,500 | 2,278 | -71% | -$428,945 | |||||
2024-05-17 | TMCI | Treace Medical Concepts, Inc. | Treace John T. | CEO, 10% | P - Purchase | $5.56 | +100,000 | 11,667,224 | +1% | +$556,170 | ||||||
| M | 2024-05-16 | SIBN | Si-Bone, Inc. | Recupero Anthony J | Pres, Commercial Ops | S - Sale | $15.01 | -6,009 | 246,938 | -2% | -$90,194 | |||||
2024-05-16 | SIBN | Si-Bone, Inc. | Maheshwari Anshul | CFO | S - Sale | $15.14 | -2,441 | 204,489 | -1% | -$36,954 | ||||||
2024-05-16 | SIBN | Si-Bone, Inc. | Dunn Jeffrey W | Dir | S - Sale | $15.13 | -1,581 | 122,184 | -1% | -$23,922 | ||||||
2024-05-16 | NARI | Inari Medical, Inc. | Hoffman William | Dir | S - Sale | $46.60 | -40,000 | 925,359 | -4% | -$1,863,977 | ||||||
| D | 2024-05-16 | HAE | Haemonetics Corp | Strong Stewart W | Pres, Global Hospital | S - Sale+OE | $96.04 | -733 | 15,608 | -4% | -$70,397 | |||||
2024-05-16 | HAE | Haemonetics Corp | Basil Michelle L | EVP, GC | S - Sale | $96.14 | -985 | 30,425 | -3% | -$94,698 | ||||||
2024-05-16 | HAE | Haemonetics Corp | Llorens Josep | EVP, Global Manufacturing | S - Sale | $96.14 | -770 | 17,172 | -4% | -$74,028 | ||||||
2024-05-15 | RMD | Resmed Inc | De Witte Jan | Dir | S - Sale | $218.29 | -360 | 7,519 | -5% | -$78,584 | ||||||
2024-05-15 | BDX | Becton Dickinson & Co | Goette Roland | EVP, Pres EMEA | S - Sale | $236.74 | -3,300 | 12,493 | -21% | -$781,224 | ||||||
| D | 2024-05-15 | GKOS | Glaukos Corp | Stapley Marc | Dir | S - Sale+OE | $112.80 | -6,250 | 32,360 | -16% | -$704,993 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |